Stimulate bone formation

Stimulate bone formation with Preotact®

Osteoporosis is a bone disease in which bone resorption exceeds bone formation resulting in reduced bone mineral density that increases risk of bone fracture. Osteoporosis and reduced bone formation is most common in women after menopause due to estrogen deficiency this is also known as postmenopausal osteoporosis. 

Preotact® is a new treatment that can stimulate bone formation. Preotact® is a parathyroid hormone that can build bone and reduce the risk of osteoporosis related fractures. Parathyroid hormone is an anabolic bone stimulating agent. It is injected daily to stimulate bone formation and increase bone mass.

Log in to learn more about how to stimulate bone formation

Nycomed

Nycomed is a European pharmaceutical company that has over 20 years’ experience of working with osteoporosis. Nycomed operates throughout Europe and in fast-growing markets in Latin America, Russia/CIS and Asia-Pacific.

Nycomed provides medicines and products for hospitals, specialists and general practitioners, as well as over-the-counter medicines in selected markets. Offering a broad portfolio of products in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management.